Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $2.874B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,363,379 | $420M | 14.6% | $60.72 | +53.8% | COM | 670703107 |
| ACLX | ARCELLX INC | 4,371,601 | $335M | 11.7% | $40.13 | +115.3% | COMMON STOCK | 03940C100 |
| ARGX | ARGENX SE | 481,305 | $296M | 10.3% | $406.28 | — | SPONSORED ADR | 04016X101 |
| RVMD | REVOLUTION MEDICINES INC | 6,553,111 | $287M | 10.0% | $36.46 | +38.4% | COM | 76155X100 |
| JANX | JANUX THERAPEUTICS INC | 3,515,986 | $188M | 6.5% | $48.02 | +10.2% | COM | 47103J105 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,531,896 | $140M | 4.9% | $25.60 | +77.4% | COM | 87650L103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,493,929 | $120M | 4.2% | $22.36 | +42.4% | COM | 28036F105 |
| PCVX | VAXCYTE INC | 1,422,787 | $116M | 4.1% | $86.04 | +15.4% | COM | 92243G108 |
| ONC | BEIGENE LTD | 616,024 | $114M | 4.0% | $197.65 | — | SPONSORED ADR | 07725L102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,910,761 | $97.7M | 3.4% | $25.24 | +121.6% | COM | 22663K107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1,772,211 | $95.97M | 3.3% | $48.85 | +4.5% | CLASS A ORD | 61559X104 |
| IRON | DISC MEDICINE INC | 1,497,720 | $94.96M | 3.3% | $48.64 | +18.9% | COM | 254604101 |
| — | MERUS N V | 1,689,922 | $71.06M | 2.5% | $57.54 | — | COM | N5749R100 |
| VERA | VERA THERAPEUTICS INC | 1,437,339 | $60.79M | 2.1% | $39.45 | +12.2% | CL A | 92337R101 |
| APGE | APOGEE THERAPEUTICS INC | 1,283,766 | $58.15M | 2.0% | $48.22 | +5.8% | COM | 03770N101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,304,970 | $42.59M | 1.5% | $8.25 | +21.1% | COM | 68062P106 |
| PLRX | PLIANT THERAPEUTICS INC | 3,197,050 | $42.11M | 1.5% | $12.54 | +8.8% | COM | 729139105 |
| IMTX | IMMATICS N.V | 5,414,409 | $38.5M | 1.3% | $9.89 | -13.2% | SHS | N44445109 |
| COGT | COGENT BIOSCIENCES INC | 4,917,412 | $38.36M | 1.3% | $8.16 | +22.1% | COM | 19240Q201 |
| SYRE | SPYRE THERAPEUTICS INC | 1,527,205 | $35.55M | 1.2% | $28.10 | +4.4% | COM NEW | 00773J202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,820,079 | $34.89M | 1.2% | $19.51 | +11.4% | COM | 92790C104 |
| — | Y-MABS THERAPEUTICS INC | 4,236,346 | $33.17M | 1.2% | $14.19 | — | COM | 984241109 |
| ERAS | ERASCA INC | 10,752,354 | $26.99M | 0.9% | $2.37 | +15.7% | COM | 29479A108 |
| TECX | TECTONIC THERAPEUTIC INC | 485,105 | $22.4M | 0.8% | $42.29 | 0.0% | COM | 878972108 |
| LENZ | LENZ THERAPEUTICS INC | 770,455 | $22.24M | 0.8% | $30.48 | 0.0% | COM | 52635N103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 400,000 | $17.29M | 0.6% | $32.56 | 0.0% | COM | 80706P103 |
| ORKA | ORUKA THERAPEUTICS INC | 819,660 | $15.89M | 0.6% | $33.52 | -27.2% | COM | 687604108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 276,439 | $9.084M | 0.3% | $46.98 | 0.0% | COM | 00847X104 |